Thermoregulation — Comprehensive

Overview

Normal body temperature — definitions and the defended range

The body is conceptualised as a core (deep tissues — brain, heart, viscera — held tightly at ~37 degrees C) and a shell (skin and superficial tissue, which varies widely and acts as the heat-exchange buffer). The defended normal core range is 36-37.5 degrees C, with a characteristic circadian rhythm of ~0.5-1.0 degrees C (nadir in early morning ~04:00-06:00, peak in late afternoon/evening ~16:00-18:00). This rhythm is the reason perioperative temperature thresholds and "fever" definitions must be interpreted against the time of day, and why night-shift ICU fevers may reflect the circadian nadir being exceeded rather than a new infective process. [1]

Core temperature is what the hypothalamus defends and what matters clinically; peripheral/shell temperature is a heat-exchange variable. Measurement sites approximate core to varying fidelity: [1]

[1]

Key point for exams: during TTM, use a fast-responding core surrogate (oesophageal, nasopharyngeal, bladder, or PA) — rectal lags too much to titrate cooling safely. During anaesthesia, the redistribution phase drops core temperature ~1-1.5 degrees C in the first 30-60 minutes as warm core blood is shunted to the periphery by vasodilation — the basis of inadvertent perioperative hypothermia.[4]

Heat production — the five mechanisms

Resting heat production (~80 W at rest) comes overwhelmingly from basal metabolic rate (BMR): the viscera (liver, brain, heart, kidneys) and the obligatory activity of ion pumps (Na+/K+ ATPase consumes ~20-30% of resting ATP). When heat is lost faster than BMR replaces it, the hypothalamus recruits four additional calorigenic mechanisms: [1]

1. Basal metabolic rate (BMR) — 70-80% of resting heat. Determined by thyroid hormone set-point, lean body mass, age and sex. This is the baseline over which the other mechanisms operate.
2. Shivering thermogenesis — up to ~5x BMR. Involuntary, asynchronous, high-frequency (8-12 Hz) contractions of skeletal muscle (no net limb movement — agonists and antagonists co-contract). Driven by shivering-command neurons in the dorsomedial hypothalamus descending via the reticulospinal tract to anterior horn cells. It is metabolically expensive and limited by muscle glycogen and cardiovascular reserve — which is why uncontrolled shivering during TTM is harmful.
3. Non-shivering thermogenesis (NST) — brown adipose tissue (BAT). BAT mitochondria express uncoupling protein 1 (UCP1 / thermogenin) in the inner membrane, which short-circuits the proton gradient so that oxidative phosphorylation dissipates energy as heat rather than driving ATP synthase. NST is the DOMINANT cold-defence in neonates (who cannot shiver effectively and have a large surface-area-to-mass ratio), and was historically thought to be absent in adult humans — modern 18-FDG PET confirms metabolically active BAT depots in the supraclavicular and paraspinal regions of adults, recruited by cold and sympathetic (beta-3 adrenergic) stimulation.
4. Voluntary exercise. Skeletal muscle contraction can raise heat production 10-15x briefly; behaviourally recruited (stamping, moving) as a conscious cold response.
5. Hormonal calorigenesis. Thyroid hormone (T3/T4) up-regulates Na+/K+ ATPase expression and mitochondrial uncoupling over hours-days (slow, genomic, sets the BMR baseline — hypothyroidism causes cold intolerance and hypothermia; hyperthyroidism causes heat intolerance). Catecholamines (noradrenaline/adrenaline) raise metabolic rate within minutes via beta-adrenergic stimulation of glycogenolysis, lipolysis and BAT. The thyroid-catecholamine synergy (thyroid hormone up-regulates beta-receptor density) explains the explosive hypermetabolism and hyperthermia of thyroid storm. [1]

[1]

Heat loss — the four physical mechanisms

Heat is lost from the body-shell interface to the environment by four physical processes. The proportions are for a resting, clothed person in a temperate room (~22 degrees C): [1]

[1]

Critical exam numerics: radiation ~60%, evaporation ~25%, convection ~12%, conduction ~3%. Note that as ambient temperature rises towards body temperature, radiation/convection/conduction all fall toward zero and then reverse (the environment heats the body), so evaporation (sweating) becomes the ONLY effective heat-loss mechanism when ambient temperature exceeds skin temperature — this is why high ambient humidity (which blocks evaporation) is so dangerous, and why heat stroke is an environmental failure of evaporative loss.[1]

Hypothalamic control — the integrator and the set point

The thermoregulatory system is a classical negative-feedback control loop with a defended set point. The central integrator is the preoptic area of the anterior hypothalamus (PO/AH). [1]

Afferent (input) limb:

• Central (core) thermoreceptors: warm-sensitive neurons in the PO/AH itself fire faster when local brain/blood temperature rises. This is the primary feedback signal — the hypothalamus senses its own temperature.
• Peripheral thermoreceptors: cold and warm receptors in the skin (and some in viscals/spinal cord) provide feed-forward information about the external thermal environment, allowing the hypothalamus to begin defending core temperature BEFORE it changes — this is why stepping into a cold room triggers vasoconstriction almost instantly. [1]

Integrator (the PO/AH): warm-sensitive PO/AH neurons compare the integrated thermal signal with the defended set point. The set point is itself dynamic — it is raised by PGE2 (fever) and by the circadian rhythm, and is influenced by ovarian hormones (luteal-phase ~0.3-0.5 degrees C rise). Additional hypothalamic nodes now recognised include the dorsomedial hypothalamus (DMH), which relays the shivering command, and the raphe pallidus in the medulla, the final common sympathetic output pathway to BAT and skin vasculature.[3]

Efferent (output) limb — two channels: [1]

[1] [1]

Fever vs hyperthermia — the pivotal exam distinction

This single distinction is examined relentlessly because it changes management. Both present with a high body temperature, but the underlying pathophysiology is opposite. [1]

Fever — the set point is RAISED

In fever, exogenous pyrogens (bacterial endotoxin/LPS, viral particles) and endogenous pyrogens (IL-1, IL-6, TNF-alpha) act on the organum vasculosum of the lamina terminalis (OVLT) — a circumventricular organ with a permeable blood-brain barrier. This activates phospholipase A2 and cyclo-oxygenase (COX) to convert arachidonic acid to prostaglandin E2 (PGE2) in the PO/AH. PGE2 raises the defended set point (e.g., from 37 to 39 degrees C). The hypothalamus now perceives the body as too COLD relative to the new set point and mounts a cold response: the patient feels cold and shivers ("rigors"), and cuts heat loss by vasoconstriction (pale, cold peripheries), until core temperature climbs to the new set point. Once reached, the patient's temperature plateaus and the peripheries vasodilate ("the fever breaks"). When the pyrogen signal resolves (or an antipyretic is given), PGE2 falls, the set point drops back to 37, and the patient now feels hot and sweats/vasodilates to cool to the new (normal) set point. [1]

Antipyretics work by blocking PGE2 synthesis. Paracetamol (central COX inhibition / putative COX-3), aspirin and NSAIDs (ibuprofen, diclofenac) all reduce PGE2 → lower the set point → the hypothalamus drives heat-loss responses. Antipyretics therefore ONLY work when the set point is elevated (fever) — they have NO effect when the set point is normal (hyperthermia). [1]

Hyperthermia — the set point is NORMAL

In hyperthermia, the set point remains at ~37 degrees C but heat load or heat production exceeds the maximum capacity for heat loss. The hypothalamus is already driving maximal heat-loss responses (sweating, vasodilation) but is overwhelmed. Causes include:

• Environmental: heat stroke (classic or exertional) — failed evaporative loss at high ambient temperature/humidity.
• Uncontrolled endogenous heat production: malignant hyperthermia (ryanodine receptor → uncontrolled SR Ca2+ release → sustained muscle contraction), neuroleptic malignant syndrome (D2 blockade), serotonin syndrome, thyroid storm, status epilepticus, salicylate overdose (uncoupling of oxidative phosphorylation).
• Impaired heat loss: anticholinergic toxicity (blocks sweating), antihistamines, severe skin disease (burns). [1]

Antipyretics are INEFFECTIVE in hyperthermia because the set point is not elevated. Treatment is active cooling (evaporative, ice-water immersion, intravascular cooling, cold IV fluids) plus, where relevant, specific antidotes (dantrolene for malignant hyperthermia; bromocriptine/dantrolene and cooling for NMS; cyproheptadine for serotonin syndrome). [1]

[1]

Targeted temperature management (TTM) — applied hypothermia

After cardiac arrest, controlled mild hypothermia (now termed targeted temperature management) improves neurological outcome. Current practice (ILCOR) targets 32-36 degrees C for at least 24 hours in comatose adults after witnessed out-of-hospital cardiac arrest with a shockable rhythm, and is considered for other arrests. The physiological rationale rests on the van 't Hoff / Q10 effect on metabolism. [1]

Mechanism of neuroprotection

Lowering temperature reduces the rate of all temperature-dependent biochemical reactions. The clinically taught figure is that cerebral metabolic rate falls by approximately 6-7% for every 1 degree C reduction in temperature — so cooling from 37 to 33 degrees C (a 4 degrees C drop) reduces cerebral oxygen consumption by roughly 25-30%, buying time for the injured, energy-depleted brain during the vulnerable early reperfusion window. Beyond simple metabolic suppression, hypothermia also: [1]

[1]

The hazard of shivering during TTM

Because the PO/AH set point is normal (~37 degrees C) in a post-arrest patient, cooling to 33 degrees C creates a 4-degree error signal that the hypothalamus fights with its most powerful weapon: shivering, which can raise metabolic rate up to 5x and cerebral O2 consumption dramatically — directly opposing the neuroprotective goal. Shivering must therefore be suppressed: sedation, opiates (especially meperidine via central shivering-receptor action), buspirone, skin-surface warming (counter-warming of face/limbs reduces the peripheral cold afferent), magnesium, and — if refractory — neuromuscular blockade with continuous EEG monitoring (since the paralysed, cooled patient cannot be clinically assessed for seizures). The Bedside Shivering Assessment Scale (BSAS) is used to titrate this.[5][6]

Complications of TTM

Hypothermia is not benign — every degree of cooling carries predictable physiological effects that must be anticipated and managed: [1]

Poikilothermia — loss of the hypothalamic loop

Poikilothermia is the loss of active thermoregulation such that body temperature drifts passively towards ambient (like a reptile). It occurs when the hypothalamic control loop is interrupted at any point: [1]

• High (cervical) spinal cord injury: the hypothalamus (PO/AH) is intact and senses temperature, but the descending sympathetic and somatic efferents cannot reach the heart, vasculature, brown fat or skeletal muscle below the lesion. Cutaneous vasomotor control and shivering (below the lesion) are lost; the patient becomes poikilothermic, drifting towards room temperature — hypothermic in a cold ICU, hyperthermic in a warm room. Limited residual control above the lesion (facial/suprapubic sweating, arm shivering) persists.
• Brain death: destruction of the PO/AH integrator itself removes the central controller; the body becomes poikilothermic. This is one of the clinical observations supporting the diagnosis and a reason organ donors require active warming to maintain a temperature compatible with organ viability.
• Severe hypothermia itself: below ~30 degrees C, the hypothalamic integrator ceases to function effectively and the patient becomes poikilothermic — a key reason not to declare death in severe hypothermia ("not dead until warm and dead").
• Anaesthesia and deep sedation: abolish the BEHAVIOURAL response and blunt the autonomic response, producing functional poikilothermia — the physiological basis of inadvertent perioperative hypothermia and the reason anaesthetised ICU patients need active warming.[4]

Exam practice — SAQs

[1]

Clinical pearls

[1]

Red flags

Key trials and evidence

[1] [1] [1]

Prognosis

Prognosis in thermoregulatory disorders is dictated by the underlying cause, the magnitude and DURATION of temperature deviation, and the speed of correction: [1]

• Heat stroke: mortality correlates directly with the duration and peak of hyperthermia — cooling delayed beyond ~30 minutes carries mortality up to 50-80%; rapid ice-water immersion (exertional) drops mortality to <5%. End-organ injury (AKI, liver failure, DIC, rhabdomyolysis, ARDS) drives outcome.[1]
• Malignant hyperthermia: untreated mortality ~70-90%; with prompt dantrolene and trigger cessation, mortality is now <5%. The earlier dantrolene is given, the better the outcome.[1]
• Targeted temperature management after cardiac arrest: TTM roughly doubles the odds of good neurological outcome; the HACA and Bernard RCTs gave an NNT of ~6 for favourable outcome. Benefit is greatest in shockable-rhythm out-of-hospital arrest; the precise target (33 vs 36 degrees C) is less important than fever prevention and protocolised post-arrest care.[5][6]
• Poikilothermia (spinal cord injury / brain death): temperature itself is a manage-and-control problem rather than a prognostic marker — outcome is determined by the underlying neurological injury. In organ donors, active warming to maintain normothermia preserves graft viability.
• Severe accidental hypothermia: governed by the Swiss staging (I — conscious, shivering; II — impaired consciousness, no shivering; III — unconscious, vital signs present; IV — no vital signs, apparent death) and the principle of "not dead until warm and dead" — survival with good neurological outcome is possible after prolonged cardiac arrest if the patient is rewarmed with extracorporeal life support before pronouncement.

[1]

References

1. [1]Bouchama A, Knochel JP Heat stroke N Engl J Med, 2002.PMID 12075060
2. [2]Romanovsky AA Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system Am J Physiol Regul Integr Comp Physiol, 2007.PMID 17008453
3. [3]DiMicco JA, Zaretsky DV The dorsomedial hypothalamus: a new player in thermoregulation Am J Physiol Regul Integr Comp Physiol, 2007.PMID 16959861
4. [4]Lenhardt R The effect of anesthesia on body temperature control Front Biosci (Schol Ed), 2010.PMID 20515846
5. [5]Hypothermia after Cardiac Arrest Study Group Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest N Engl J Med, 2002.PMID 11856793
6. [6]Arrich J, Holzer M, Havel C, Mullner M, Herkner H Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation Cochrane Database Syst Rev, 2016.PMID 26878327